|
Cognitive Screening Made Easy for PCPs - Administrative Supplement
RECRUITINGN/ASponsored by University of Texas at Austin
Actively Recruiting
PhaseN/A
SponsorUniversity of Texas at Austin
Started2025-06-10
Est. completion2026-12-31
Eligibility
Age60 Years+
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT06928298
Summary
This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will be easier to screen for cognitive impairment, increasing the number of older adults who are screened and thus identified and treated.
Eligibility
Age: 60 Years+Healthy volunteers accepted
Inclusion Criteria: * Inclusion Criteria: * Aged 60 years and older; * Ethnic/racial background consistent with NIH policy * Male or female * Fluent in Spanish. Exclusion Criteria: * Confounding conditions that could impact ability to participate in the study (e.g., cognitive impairment sufficient to impact ability to follow instructions on the iPad, motor impairment that would prohibit independent use of RACS, poor visual acuity) * Prior diagnosis of dementia * Non-Spanish speaking.
Conditions4
CancerCognitive DeclineCognitive ImpairmentDementia, Mild
Locations3 sites
University of Texas Health Austin Primary Care Clinic
Austin, Texas, 78712
Scott Selinger Selinger, MDscott.selinger@austin.utexas.edu
UT Health San Antonio's Geriatrics and Supportive Care Clinic
San Antonio, Texas, 78229
Angelica Davila, MD2104509890
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Texas at Austin
Started2025-06-10
Est. completion2026-12-31
Eligibility
Age60 Years+
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →
NCT06928298